The bivariate analysis showed that ASDAS-CRP at the end of the study was significantly lower in nr-ax-SpA disease than in r-ax-SpA (1.4 versus 2.2, p = 0.02), and in patients without fibromyalgia (1.4 versus 2.5, p < 0.001). This evidence concerns the gene CRP and fibromyalgia.